Coronary atherosclerosis and cardiovascular mortality in hemophilia

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Thrombosis and Haemostasis

• Publication date

  2010-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1538-7836.2009.03669.xPMID 19874455PMCID PMC2881951
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Type IIB von Willebrand Disease: Role of Qualitative Defects in Atherosclerosis and Endothelial Dysfunction

  2007cited by this paper
• Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV.

  2007cited by this paper
• Does Hemophilia Protect Against Atherosclerosis? A Case-Control Study

  2006cited by this paper
• Haemostatic Factors and the Risk of Cardiovascular Death in Patients With Coronary Artery Disease: The AtheroGene Study

  2006cited by this paper
• Mortality and causes of death in patients with hemophilia, 1992–2001: a prospective cohort study 1

  2006cited by this paper
• Role of the Intrinsic Coagulation Pathway in Atherogenesis Assessed in Hemophilic Apolipoprotein E Knockout Mice

  2005cited by this paper
• Prevalence and risk factors for heart disease among males with hemophilia

  2005cited by this paper
• Patients With Type 3 Severe von Willebrand Disease Are Not Protected Against Atherosclerosis: Results From a Multicenter Study in 47 Patients

  2004cited by this paper
• Decreased mortality of ischaemic heart disease among carriers of haemophilia.

  2003cited by this paper
• Intrinsic pathway of blood coagulation contributes to thrombogenicity of atherosclerotic plaque.

  2002cited by this paper
• Hemophilia A, von Willebrand Disease, and Atherosclerosis of Abdominal Aorta and Leg Arteries: Factor VIII and von Willebrand Factor Defects Appear to Protect Abdominal Aorta and Leg Arteries From Atherosclerosis

  2001cited by this paper
• Decreased Coagulability Has No Clinically Relevant Effect on Atherogenesis: Observations in Individuals With a Hereditary Bleeding Tendency

  2001cited by this paper
• High plasma levels of factor VIII and the risk of recurrent venous thromboembolism.

  2000cited by this paper
• Do Hemophilia A and von Willebrand Disease Protect Against Carotid Atherosclerosis? A Comparative Study Between . Coagulopathics and Normal Subjects by Means of Carotid Echo-Color Doppler Scan

  1999cited by this paper
• Acute coronary syndromes: biology

  1999cited by this paper
• Tissue factor modulates the thrombogenicity of human atherosclerotic plaques.

  1997cited by this paper
• Mortality in Patients with Hemophilia: Changes in a Dutch Population from 1986 to 1992 and 1973 to 1986

  1995cited by this paper
• Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis.

  1995cited by this paper
• Determinants of femoral and carotid artery atherosclerosis

  1994cited by this paper
• Acquired immunodeficiency syndrome-associated non-Hodgkin's lymphomas and other malignancies in patients with hemophilia.

  1993cited by this paper
• Risk Factors and Early Extracoronary Atherosclerotic Plaques Detected by Three-Site Ultrasound Imaging in Hypercholesterolemic Men

  1991cited by this paper
• Risk factors and early extracoronary atherosclerotic plaques detected by three-site ultrasound imaging in hypercholesterolemic men. Prévention Cardio-vasculaire en Médecine du Travail METRA Group.

  1991cited by this paper
• Haemophilia protects against ischaemic heart disease: a study of risk factors

  1990cited by this paper
• [AIDS-associated non-Hodgkin's lymphoma].

  1989cited by this paper

• Use of coagulation factor concentrates and blood transfusion in cardiac surgery: a retrospective cohort study of adults with hereditary and acquired bleeding disorders.

  2024cites this paper
• Debates Surrounding the Use of Antithrombotic Therapy in Hemophilic Patients with Cardiovascular Disease: Best Strategies to Minimize Severe Bleeding Risk

  2024cites this paper
• Lipid Profile of Children and Adolescents with Hemophilia at Zagazig University Hospitals

  2022cites this paper
• Bone health in haemophilia carriers and persons with von Willebrand disease: A large database analysis

  2022cites this paper
• Blood pressure in persons with haemophilia with a focus on haemophilia‐specific risk factors

  2022cites this paper
• Hypertension in haemophilia: A meta‐analysis

  2022cites this paper
• Diabetes, hepatitis C and human immunodeficiency virus influence hypertension risk differently in cohorts of haemophilia patients, veterans and the general population

  2022cites this paper
• Cardiovascular Risk Factors in Patients with Congenital Hemophilia: A Focus on Hypertension

  2022cites this paper
• Current Therapeutic Approach to Atrial Fibrillation in Patients with Congenital Hemophilia

  2022cites this paper
• Clinical burden of hemophilia in older adults: Beyond bleeding risk.

  2021cites this paper
• Current Therapeutic Approach to Acute Myocardial Infarction in Patients with Congenital Hemophilia

  2021cites this paper
• Mortality in congenital hemophilia A – a systematic literature review

  2020cites this paper
• Prevalence of Metabolic Syndrome and Risk Factors for Cardiovascular Disease in Hemophilia Patients Compared to a Control Group in South Khorasan, Iran

  2020cites this paper
• Evaluation of Ischemic Heart Disease Factors in Hemophilia Patients in Khorramabad.

  2020cites this paper
• Cardiac surgery in patients with Hemophilia:is it safe?

  2020cites this paper
• Confounding effect of therapeutic protamine and heparin levels on routine and special coagulation testing.

  2020cites this paper
• A study of correlation of d- dimer with severity of peripheral arterial disease in a tertiary care center of North India: Original research article

  2019cites this paper
• Substantial prevalence of subclinical cardiovascular diseases in patients with hemophilia A evaluated by advanced electrocardiography.

  2019cites this paper
• Risk factors for cardiovascular disease in children and young adults with haemophilia

  2018cites this paper
• Bleeding risk for patients with haemophilia under antithrombotic therapy. Results of the French multicentric study ERHEA

  2018cites this paper
• Hemophilia A and Hemophilia B

  2018cites this paper
• Prevalence and impact of obesity in people with haemophilia: Review of literature and expert discussion around implementing weight management guidelines

  2017cites this paper
• Management of Hemophilia in Older Patients

  2017cites this paper
• Increased plasma thrombin potential is associated with stable coronary artery disease: An angiographically-controlled study.

  2017cites this paper
• Prevalence of Hypertension (HTN) and Cardiovascular Risk Factors in a Hospitalized Pediatric Hemophilia Population

  2017cites this paper
• Perioperative management of rare coagulation factor deficiency states in cardiac surgery

  2017cites this paper
• Część I: Wytyczne postępowania w hemofilii A i B niepowikłanej inhibitorem czynnika VIII i IX (wydanie zaktualizowane)

  2016cites this paper
• Hypertension, haematuria and renal functioning in haemophilia – a cross‐sectional study in Europe

  2016cites this paper
• Understanding cardiovascular risk in hemophilia: A step towards prevention and management.

  2016cites this paper
• Aging among persons with hemophilia: contemporary concerns.

  2016cites this paper
• AKAP150 participates in calcineurin/NFAT activation during the down-regulation of voltage-gated K(+) currents in ventricular myocytes following myocardial infarction.

  2016cites this paper
• How I treat patients with inherited bleeding disorders who need anticoagulant therapy.

  2016cites this paper
• Presentation and management of acute coronary syndromes among adult persons with haemophilia: results of an international, retrospective, 10‐year survey

  2015cites this paper
• Managing older patients with hemophilia.

  2015cites this paper
• Consensus Review of the Treatment of Cardiovascular Disease in People With Hemophilia A and B

  2015cites this paper
• Cardiovascular disease prevalence and relevance in haemophilia: a scoping review

  2015cites this paper
• Comorbidities and inhibitors in adult patients with haemophilia: issues, costs and management strategies

  2015cites this paper
• Prevalence and risk factors of atherothrombotic events among 1054 hemophilia patients: a population-based analysis.

  2015cites this paper
• Prevention and treatment of atherosclerosis in haemophilia – how to balance risk of bleeding with risk of ischaemic events

  2015cites this paper
• Differential cellular effects of old and new oral anticoagulants: consequences to the genesis and progression of atherosclerosis

  2014cites this paper
• A cross-sectional analysis of cardiovascular disease in the hemophilia population.

  2014cites this paper
• UvA-DARE ( Digital Academic Repository ) Factor XI as target for antithrombotic therapy

  2014cites this paper
• Risk assessment for coronary heart disease in patients with haemophilia: a single centre study in the United States

  2014cites this paper
• The impact of blood coagulability on atherosclerosis and cardiovascular disease: reply to a rebuttal

  2013cites this paper
• 4 – Hemophilia A and B

  2013cites this paper
• Antikoagulatorische Therapie bei Hämophilie

  2013cites this paper
• Anticoagulation beyond direct thrombin and factor Xa inhibitors: indications for targeting the intrinsic pathway?

  2013cites this paper
• Prevalence and Risk Factors for Hypertension in Hemophilia

  2013cites this paper
• Emerging Issues on Comprehensive Hemophilia Care: Preventing, Identifying, and Monitoring Age-Related Comorbidities

  2013cites this paper
• Anticoagulation therapy in haemophilia.

  2013cites this paper
• The impact of blood coagulability on atherosclerosis and cardiovascular disease: a rebuttal

  2013cites this paper
• Hemophilia A in the third millennium.

  2013cites this paper
• Anticoagulation therapy in haemophilia

  2013cites this paper
• Prognosis after cerebral ischaemia of arterial origin: clinical characteristics and genetic information

  2013cites this paper
• Coronary artery calcification score and carotid intima–media thickness in patients with hemophilia

  2012cites this paper
• Factor VIII deficiency does not protect against atherosclerosis

  2012cites this paper
• Management of bleeding disorders in the elderly

  2012cites this paper
• An algorithmic approach to peripheral artery disease in hemophilia: extrapolation of management principles from noncoagulopathic patients

  2012cites this paper
• The impact of blood coagulability on atherosclerosis and cardiovascular disease

  2012cites this paper
• Increased prevalence of hypertension in haemophilia patients

  2012cites this paper
• Therapeutic problems in elderly patients with hemophilia.

  2012cites this paper
• The hope and reality of long‐acting hemophilia products

  2012cites this paper
• The aging patient with hemophilia

  2012cites this paper
• Unfavourable cardiovascular disease risk profiles in a cohort of Dutch and British haemophilia patients

  2012cites this paper
• Rationale for a randomized controlled trial comparing two prophylaxis regimens in adults with severe hemophilia A: the Hemophilia Adult Prophylaxis Trial

  2011cites this paper
• Prevalence and risk factors of cardiovascular disease (CVD) events among patients with haemophilia: experience of a single haemophilia treatment centre in the United States (US)

  2011cites this paper
• Sexual evaluation and treatment of ageing males with haemophilia

  2011cites this paper
• Differential propensity for major hemorrhagic events in patients with different types of arterial disease

  2011cites this paper
• Aging in Haemophilia: Getting to the heart of the matter

  2011cites this paper
• Associations between cardiovascular risk factors, hyper- and hypocoagulability

  2011cites this paper
• Novel insights into the development of atherosclerosis in hemophilia A mouse models

  2011cites this paper
• Atherosclerotic heart disease: prevalence and risk factors in hospitalized men with haemophilia A

  2011cites this paper
• Porcine and Canine von Willebrand Factor and von Willebrand Disease: Hemostasis, Thrombosis, and Atherosclerosis Studies

  2011cites this paper
• Myocardial infarction in a patient with moderate haemophilia A Zawał mięśnia sercowego u pacjenta z umiarkowaną hemofilią A

  2011cites this paper
• Case report Myocardial infarction in a patient with moderate haemophilia A

  2011cites this paper
• The aging patient with hemophilia: complications, comorbidities, and management issues.

  2010cites this paper
• The challenge of an ageing haemophilic population

  2010cites this paper
• Bibliography--editors' selection of current world literature.

  2010cites this paper
• Factor XI as target for antithrombotic therapy

  year unknowncites this paper
• Factor XI as target for antithrombotic therapy

  year unknowncites this paper